Another recent study considered 100 Korean patients with pediatric ALL and evaluated in these patients 18 loci in 16 candidate genes of pharmacogenetic interest, including TPMT and ITPA, and their association with survival rate. The gene discussed is ITPA; the disease is acute lymphoblastic leukemia.